JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 131 filers reported holding JOUNCE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 5.36 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $273,000 | +145.9% | 40,853 | +282.9% | 0.00% | – |
| Q1 2021 | $111,000 | -89.8% | 10,669 | -92.9% | 0.00% | -100.0% |
| Q4 2020 | $1,086,000 | +7.6% | 150,731 | +38.2% | 0.00% | 0.0% |
| Q3 2020 | $1,009,000 | +34.0% | 109,061 | -7.6% | 0.00% | 0.0% |
| Q2 2020 | $753,000 | +50.9% | 118,074 | +5.5% | 0.00% | 0.0% |
| Q1 2020 | $499,000 | +2395.0% | 111,875 | +4901.1% | 0.00% | – |
| Q4 2019 | $20,000 | +300.0% | 2,237 | +56.1% | 0.00% | – |
| Q3 2019 | $5,000 | -44.4% | 1,433 | -24.5% | 0.00% | – |
| Q2 2019 | $9,000 | +125.0% | 1,898 | +222.2% | 0.00% | – |
| Q1 2019 | $4,000 | +300.0% | 589 | +181.8% | 0.00% | – |
| Q4 2018 | $1,000 | -50.0% | 209 | +2.0% | 0.00% | – |
| Q3 2018 | $2,000 | 0.0% | 205 | -1.4% | 0.00% | – |
| Q2 2018 | $2,000 | – | 208 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 2,697,829 | $22,527,000 | 93.16% |
| TRV GP III, LLC | 1,148,780 | $9,592,000 | 2.40% |
| Deep Track Capital, LP | 4,000,000 | $33,400,000 | 2.36% |
| Ally Bridge Group (NY) LLC | 575,000 | $4,801,000 | 1.68% |
| Logos Global Management LP | 1,350,000 | $11,273,000 | 1.16% |
| PFM Health Sciences, LP | 3,972,868 | $33,173,000 | 1.13% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 245,829 | $2,053,000 | 0.83% |
| Yorktown Management & Research Co Inc | 137,300 | $1,146,000 | 0.77% |
| Sofinnova Investments, Inc. | 1,582,777 | $13,216,000 | 0.77% |
| ACUTA CAPITAL PARTNERS, LLC | 127,500 | $1,065,000 | 0.45% |